- Home
- BSII vs SENS Comparison
BSII vs SENS Comparison
Compare BSII & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSII
- SENS
- Stock Information
- Founded
- BSII 2024
- SENS 1996
- Country
- BSII Hong Kong
- SENS United States
- Employees
- BSII N/A
- SENS N/A
- Industry
- BSII
- SENS Industrial Machinery/Components
- Sector
- BSII
- SENS Industrials
- Exchange
- BSII Nasdaq
- SENS Nasdaq
- Market Cap
- BSII 189.9M
- SENS 179.7M
- IPO Year
- BSII 2024
- SENS N/A
- Fundamental
- Price
- BSII $9.93
- SENS $1.13
- Analyst Decision
- BSII
- SENS Strong Buy
- Analyst Count
- BSII 0
- SENS 1
- Target Price
- BSII N/A
- SENS $2.00
- AVG Volume (30 Days)
- BSII 3.2K
- SENS 19.5M
- Earning Date
- BSII 01-01-0001
- SENS 02-27-2025
- Dividend Yield
- BSII N/A
- SENS N/A
- EPS Growth
- BSII N/A
- SENS N/A
- EPS
- BSII N/A
- SENS N/A
- Revenue
- BSII N/A
- SENS $22,205,000.00
- Revenue This Year
- BSII N/A
- SENS $0.43
- Revenue Next Year
- BSII N/A
- SENS $60.55
- P/E Ratio
- BSII N/A
- SENS N/A
- Revenue Growth
- BSII N/A
- SENS 11.41
- 52 Week Low
- BSII $9.86
- SENS $0.25
- 52 Week High
- BSII $10.30
- SENS $1.15
- Technical
- Relative Strength Index (RSI)
- BSII N/A
- SENS 81.02
- Support Level
- BSII N/A
- SENS $0.76
- Resistance Level
- BSII N/A
- SENS $1.04
- Average True Range (ATR)
- BSII 0.00
- SENS 0.12
- MACD
- BSII 0.00
- SENS 0.04
- Stochastic Oscillator
- BSII 0.00
- SENS 97.24
About BSII Black Spade Acquisition II Co Class A Ordinary Share
Black Spade Acquisition II Co is a blank check company.
About SENS Senseonics Holdings Inc.
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.